Preclinical Study of the 89Zr/177Lu-Labeled Engineered VHH-based Antibody for CLDN18.2-Targeted Radiotheranostics
- DOI
- 10.1021/acs.molpharmaceut.6c01174
- Published
- 2026-10-14
- Container
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1021/acs.molpharmaceut.6c01174,
title = {Preclinical Study of the 89Zr/177Lu-Labeled Engineered VHH-based Antibody for CLDN18.2-Targeted Radiotheranostics},
author = {Wenyu Wu and Guoqiang Shao and Yilin Xue and Jun Chen and Zhaoyang Zhao and Jingjing Fu and Rui Yang and Hai Qian and Hanmei Xu},
year = {2026},
journal = {Molecular Pharmaceutics},
doi = {10.1021/acs.molpharmaceut.6c01174},
url = {https://doi.org/10.1021/acs.molpharmaceut.6c01174}
}RIS
TY - JOUR TI - Preclinical Study of the 89Zr/177Lu-Labeled Engineered VHH-based Antibody for CLDN18.2-Targeted Radiotheranostics AU - Wenyu Wu AU - Guoqiang Shao AU - Yilin Xue AU - Jun Chen AU - Zhaoyang Zhao AU - Jingjing Fu AU - Rui Yang AU - Hai Qian AU - Hanmei Xu PY - 2026 JO - Molecular Pharmaceutics DO - 10.1021/acs.molpharmaceut.6c01174 UR - https://doi.org/10.1021/acs.molpharmaceut.6c01174 ER -
APA
Wu, W., Shao, G., Xue, Y., Chen, J., Zhao, Z., Fu, J., Yang, R., Qian, H., & Xu, H. (2026). Preclinical Study of the 89Zr/177Lu-Labeled Engineered VHH-based Antibody for CLDN18.2-Targeted Radiotheranostics. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.6c01174
Source records
- crossref · retrieved 2026-11-04T02:56:24.590Z